Related news for: clinical trial
Preparing for an around-Australia road trip was the last thing Kevin Jocumsen thought he’d ever be able to do when he was diagnosed with Stage-4 metastatic prostate cancer at the end of 2018.
Cannabis trial offers hope in National Pain Week
Despite a global health pandemic catching everyone off guard, this year has still delivered moments of joy for new parents.
Meeting milestones in the face of challenges
Pregnant women and their unborn babies can look forward to a brighter future.
Grant success aims to lower the risk of fetal distress in labour
Mater researchers, in partnership with The University of Queensland, have achieved publication in the highly-ranked journal ‘Clinical and Translational Immunology’.
Mater Researchers make early breakthrough with cancer vaccines
Grant success allows research to progress to clinical trails for post chemotherapy gynaecological cancer patients.
Post Treatment Recovery Research gets a lift from Grant Success
Today at Mater there are approximately 200 clinical trials currently underway across many disciplines including nursing and midwifery, all allied health disciplines and medical specialties.
Celebrating International Clinical Trials day
Mater Research—University of Queensland (MRI—UQ) Acting Director Professor Maher Gandhi has been awarded $3.6 million to improve treatment for relapsed lymphoma patients.
$3.6 million awarded to develop treatment for relapsed lymphoma patients
A new triple-combination drug trialled at Mater in Brisbane could increase the life expectancy of patients with cystic fibrosis (CF).
Mater helps bring new hope to patients with cystic fibrosis
A Queensland trial will evaluate the benefits of medicinal cannabis for symptom relief in cancer patients receiving palliative care.
Medicinal cannabinoids trial for symptom relief